Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC)

Core Viewpoint - Southpoint Capital Advisors LP has disposed of 1,000,000 common shares of Fennec Pharmaceuticals Inc., representing approximately 2.93% of the outstanding shares, for investment purposes [1][3]. Group 1: Share Transaction Details - The common shares were sold at a price of USD$7.50 per share [2]. - Following the sale, Southpoint now controls 2.7 million common shares, which is about 8% of the outstanding shares [2]. Group 2: Future Ownership Intentions - Southpoint may adjust its beneficial ownership of common shares depending on market conditions through various means such as market transactions or private agreements [3].